Io Therapeutics, Inc. - Product Pipeline Review - 2014

  • ID: 3045217
  • Company Profile
  • 26 pages
  • Global Markets Direct
1 of 4
Io Therapeutics, Inc. - Product Pipeline Review - 2014

Summary

This, ‘Io Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Io Therapeutics, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Io Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Io Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Io Therapeutics, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Io Therapeutics, Inc.’s pipeline products

Reasons to buy

- Evaluate Io Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Io Therapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Io Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Io Therapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Io Therapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Io Therapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables
List of Figures
Io Therapeutics, Inc. Snapshot
Io Therapeutics, Inc. Overview
Key Information
Key Facts
Io Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Io Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Io Therapeutics, Inc. - Pipeline Products Glance
Io Therapeutics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Io Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Io Therapeutics, Inc. - Drug Profiles
IRX-4204
Product Description
Mechanism of Action
R&D Progress
IRX-4310
Product Description
Mechanism of Action
R&D Progress
IRX-5183
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Io Therapeutics, Inc. - Pipeline Analysis
Io Therapeutics, Inc. - Pipeline Products by Target
Io Therapeutics, Inc. - Pipeline Products by Route of Administration
Io Therapeutics, Inc. - Pipeline Products by Molecule Type
Io Therapeutics, Inc. - Pipeline Products by Mechanism of Action
Io Therapeutics, Inc. - Recent Pipeline Updates
Io Therapeutics, Inc. - Dormant Projects
Io Therapeutics, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
IRX-4204
IRX-4310
Io Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Io Therapeutics, Inc., Key Information
Io Therapeutics, Inc., Key Facts
Io Therapeutics, Inc. - Pipeline by Indication, 2014
Io Therapeutics, Inc. - Pipeline by Stage of Development, 2014
Io Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014
Io Therapeutics, Inc. - Phase II, 2014
Io Therapeutics, Inc. - Phase I, 2014
Io Therapeutics, Inc. - Preclinical, 2014
Io Therapeutics, Inc. - Pipeline by Target, 2014
Io Therapeutics, Inc. - Pipeline by Route of Administration, 2014
Io Therapeutics, Inc. - Pipeline by Molecule Type, 2014
Io Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014
Io Therapeutics, Inc. - Recent Pipeline Updates, 2014
Io Therapeutics, Inc. - Dormant Developmental Projects,2014
Io Therapeutics, Inc. - Discontinued Pipeline Products, 2014

List of Figures
Io Therapeutics, Inc. - Pipeline by Top 10 Indication, 2014
Io Therapeutics, Inc. - Pipeline by Stage of Development, 2014
Io Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014
Io Therapeutics, Inc. - Pipeline by Top 10 Target, 2014
Io Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2014
Io Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2014
Io Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll